News and Events

Hatchtech $2.5m new funding for Phase II head lice trials

28/11/2008 | Press Releases

Hatchtech Pty Ltd has secured $2.5 million in further funding from the University of Melbourne Endowment Trust (advised by GBS Venture Partners) and from Uniseed. The investment will be used to progress its unique head lice treatment into Phase II safety/efficacy studies in humans.

Download PDF